Skip to content
Evigrade
MajorFirst-generation antipsychotic, aliphatic-side-chain phenothiazine×Selective serotonin reuptake inhibitor (SSRI)

Updated · Methodology

Mechanism

Paroxetine strongly inhibits the enzyme CYP2D6 (paroxetine label, US Food and Drug Administration, FDA). Phenothiazine neuroleptics, including chlorpromazine, are on the list of drugs cleared by CYP2D6 whose levels may rise when the enzyme is inhibited (paroxetine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). CYP1A2 inhibitors raise chlorpromazine levels, and chlorpromazine itself strongly inhibits CYP2D6. Its own labels say nothing about clearance through CYP2D6 (chlorpromazine SmPC, AEMPS). Phenothiazine neuroleptics can prolong the QT interval and trigger torsade de pointes, which can be fatal, especially with a slow heart rate, low potassium or other QT-prolonging drugs (chlorpromazine SmPC, AEMPS). In a study, paroxetine 20–60 mg did not prolong the corrected QT interval (QTc), but cases of QTc prolongation were reported after marketing. With other QTc-prolonging drugs, such as some antipsychotics, the risk of QTc prolongation and ventricular arrhythmias is higher (paroxetine SmPC, AEMPS). Rarely, paroxetine combined with neuroleptics causes serotonin syndrome or neuroleptic malignant syndrome, and phenothiazines may add to the bleeding risk of paroxetine (paroxetine SmPC, AEMPS).

Symptoms

QT prolongation itself causes no symptoms and shows only on the electrocardiogram (ECG). An arrhythmia causes palpitations, dizziness and fainting. QT prolongation is a common adverse reaction to chlorpromazine. Ventricular tachycardia and fibrillation, torsade de pointes, cardiac arrest and sudden death occur with it at unknown frequency (chlorpromazine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Higher chlorpromazine levels may strengthen its dose-dependent adverse reactions. Its most common adverse reactions are drowsiness, low blood pressure on standing, dry mouth and constipation (chlorpromazine SmPC, AEMPS). Neuroleptic malignant syndrome causes pallor, muscle rigidity, fever and autonomic disturbances, and sweating and unstable blood pressure may come before the fever (chlorpromazine SmPC, AEMPS). Serotonin syndrome causes agitation, confusion, hallucinations, sweating, chills, fast heart rate, tremor, muscle jerks and brisk reflexes (paroxetine SmPC, AEMPS). Bleeding usually shows as bruising and bleeding into the skin and mucous membranes, less often as gastrointestinal bleeding (paroxetine SmPC, AEMPS).

Management

Avoid the combination. In its September 2026 version, the US Food and Drug Administration (FDA) paroxetine label contraindicates paroxetine with drugs that prolong the QT interval and are CYP2D6 substrates (paroxetine FDA label). Chlorpromazine prolongs QT (chlorpromazine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS), and phenothiazine neuroleptics are on the list of CYP2D6 substrates (paroxetine SmPC, AEMPS). The pair itself is not contraindicated: the contraindication does not name chlorpromazine, and the chlorpromazine labels say nothing about clearance through CYP2D6 (chlorpromazine SmPC, AEMPS, and chlorpromazine FDA label). If the combination is needed, rule out risk factors for arrhythmia where possible before starting chlorpromazine: heart rate below 55 beats per minute, low potassium, congenital long QT, and other drugs that prolong QT, slow the heart or lower potassium (chlorpromazine SmPC, AEMPS). Except in emergencies, record an electrocardiogram before starting chlorpromazine (chlorpromazine SmPC, AEMPS). Use paroxetine with caution together with QT-prolonging drugs, especially with a slow heart rate, low potassium or magnesium, or heart disease (paroxetine SmPC, AEMPS). Chlorpromazine inhibits CYP2D6, so consider the lowest paroxetine dose within the therapeutic range (chlorpromazine and paroxetine SmPCs, AEMPS). Reduce the dose of CYP2D6 substrates taken with paroxetine if needed (paroxetine FDA label). Stop chlorpromazine if unexplained fever appears, as it may be the start of neuroleptic malignant syndrome (chlorpromazine SmPC, AEMPS). If serotonin syndrome or neuroleptic malignant syndrome develops, stop paroxetine too and start supportive treatment (paroxetine SmPC, AEMPS). Because of the bleeding risk, use caution when combining paroxetine with phenothiazines, especially in people with previous bleeding (paroxetine SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Chlorpromazine

Other interactions with Paroxetine